eClinical Solutions Market To Reach $10.5 Billion By 2024
“The global eClinical solutions market to witness growth based on rising demand for software solutions for clinical trials by the pharma and biopharma companies�
eClinical solutions market is expected to reach USD 10.5 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base.
Follow Us:
Detailed Research Report available at: http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future. The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF). The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa). Further key findings from the study suggest: 
In 2016, North America is estimated to lead the market with the largest share in the eClinical solutions industry. The rising number of ongoing clinical trials, high
Follow Us:
demand for technologically advanced products, and increasing financial support from the government is anticipated to boost the industry growth.
The eCOA segment is anticipated to witness the highest growth rate during the forecast period, whereas the EDC and CDMS segment is estimated to lead the market in the year 2016. Factors attributing to the growth of the industry are the increasing application of mobile and digital technologies, as well as, an upsurge in the demand for eDiaries in clinical trials for the collection of patient’s selfreports by pharmaceutical companies.
The eClinical solutions industry comprises several local as well as global players. Some of the major players in this industry include Oracle Corporation, Medidata Solutions Inc., Parexel International, Inc., and Datatrak, among others.
Read our blogs on healthcare industry: http://www.grandviewresearch.com/blogs/healthcare Table of content of global eClinical solutions market research report: Chapter 1. Methodology and Scope 1.1. Research methodology 1.2. Research scope & assumption 1.3. List of data sources Chapter 2. Executive Summary 2.1. eClinical Solutions Market - Industry Summary and Key Buying Criteria, 2013 - 2024
Follow Us:
Chapter 3. eClinical Solutions Industry Outlook 3.1. Market segmentation 3.2. Market size and growth prospects, 2013-2024 3.3. eClinical Solutions: Market dynamics 3.3.1. Market driver analysis 3.3.1.1. Increasing externalization of clinical trial studies by the large biopharma and pharma companies 3.3.1.2. Presence of a strong range of products in pipeline 3.3.2. Market restraint analysis 3.3.2.1. Scarcity of skilled research professionals 3.3.2.2. Lack of recognition 3.4. eClinical solutions market: Industry trend analysis 3.5. eClinical solutions market: PESTEL Analysis 3.6. eClinical solutions industry analysis - Porter's Five Forces Model 3.7. eClinical solutions: Company market share analysis (%), 2015 3.8. Key opportunities prioritized Chapter 4. eClinical Solutions Product Outlook
Follow Us:
4.1. eClinical Solutions Revenue Share (%) Analysis, by Product, 2016 & 2024 4.2. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 4.2.1. EDC and CDMS market revenue, by region, 2013 to 2024 (USD Million) 4.3. Clinical Trial Management Systems (CTMS) 4.3.1. CTMS market revenue, by region, 2013 to 2024 (USD Million) 4.4. Clinical Analytics Platforms 4.4.1. Market revenue, by region, 2013 to 2024 (USD Million) 4.5. Randomization and Trial Supply Management (RTSM) 4.5.1. RTSM market revenue, by region, 2013 to 2024 (USD Million) 4.6. Clinical Data Integration Platforms 4.6.1. Market revenue by region, 2013 to 2024 (USD Million) 4.7. Electronic Clinical Outcome Assessment (ECOA) 4.7.1. ECOA market revenue, by region, 2013 to 2024 (USD Million) 4.8. Safety Solutions 4.8.1. Market revenue, by region, 2013 to 2024 (USD Million)
Follow Us:
4.9. Electronic Trial Master File (eTMF) 4.9.1. eTMF market revenue, by region, 2013 to 2024 (USD Million) Chapter 5. eClinical Solutions Delivery Mode Outlook 5.1. eClinical Solutions Revenue Share (%) Analysis, by Delivery Mode, 2016 & 2024 5.2. Web-hosted (on-demand) 5.2.1. Web-hosted (on-demand) market revenue, by region, 2013 to 2024 (USD Million) 5.3. Licensed Enterprise (on premise) 5.3.1. Licensed enterprise (on premise) market revenue, by region, 2013 to 2024 (USD Million) 5.4. Cloud-Based 5.4.1. Cloud-basedmarket revenue, by region, 2013 to 2024 (USD Million) Chapter 6. eClinical Solutions Clinical Trial Outlook 6.1. eClinical Solutions Revenue Share (%) Analysis, by Clinical Trial, 2016 & 2024 6.2. Phase I 6.2.1. Phase I market revenue, by region, 2013 to 2024 (USD Million)
Follow Us:
6.3. Phase II 6.3.1. Phase II market revenue, by region, 2013 to 2024 (USD Million) 6.4. Phase III 6.4.1. Phase III market revenue, by region, 2013 to 2024 (USD Million) 6.5. Phase IV 6.5.1. Phase IV market revenue, by region, 2013 to 2024 (USD Million) Chapter 7. eClinical Solutions End-User Outlook 7.1. eClinical Solutions Revenue Share (%) Analysis, by End-User, 2016 & 2024 7.2. Hospitals 7.2.1. Hospitals market revenue, by region, 2013 to 2024 (USD Million) 7.3. CROs 7.3.1. CROs market revenue, by region, 2013 to 2024 (USD Million) 7.4. Others 7.4.1. Others market revenue, by region, 2013 to 2024 (USD Million) Chapter 8. eClinical Solutions Regional Outlook 8.1. eClinical Solutions Market Share (%) Analysis, by Region, 2016 & 2024
Follow Us:
8.2. North America 8.2.1. U.S. 8.2.1.1. U.S. eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.2.1.2. U.S. eClinical solutions market, by delivery mode, 2013 2024 (USD Million) 8.2.1.3. U.S. eClinical solutions market, by clinical trial, 2013 - 2024 (USD Million) 8.2.1.4. U.S. eClinical solutions market, by end-user, 2013 - 2024 (USD Million) 8.2.2. Canada 8.2.2.1. Canada eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.2.2.2. Canada eClinical solutions market, by delivery mode, 2013 - 2024 (USD Million) 8.2.2.3. Canada eClinical solutions market, by clinical trial, 2013 2024 (USD Million) 8.2.2.4. Canada eClinical solutions market, by end-user, 2013 2024 (USD Million) 8.3. Europe
Follow Us:
8.3.1. Germany 8.3.1.1. Germany eClinical solutions market, by product, 2013 2024 (USD Million) 8.3.1.2. GermanyeClinical solutions market, by delivery mode, 2013 - 2024 (USD Million) 8.3.1.3. Germany eClinical solutions market, by clinical trial, 2013 2024 (USD Million) 8.3.1.4. Germany eClinical solutions market, by end-user, 2013 2024 (USD Million) 8.3.2. U.K. 8.3.2.1. U.K. eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.3.2.2. U.K. eClinical solutions market, by delivery mode, 2013 2024 (USD Million) 8.3.2.3. U.K. eClinical solutions market, by clinical trial, 2013 - 2024 (USD Million) 8.3.2.4. U.K. eClinical solutions market, by end-user, 2013 - 2024 (USD Million) 8.4. Asia Pacific 8.4.1. China
Follow Us:
8.4.1.1. China eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.4.1.2. China eClinical solutions market, by delivery mode, 2013 2024 (USD Million) 8.4.1.3. China eClinical solutions market, by clinical trial, 2013 2024 (USD Million) 8.4.1.4. China eClinical solutions market, by end-user, 2013 - 2024 (USD Million) 8.4.2. India 8.4.2.1. India eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.4.2.2. India eClinical solutions market, by delivery mode, 2013 2024 (USD Million) 8.4.2.3. India eClinical solutions market, by clinical trial, 2013 2024 (USD Million) 8.4.2.4. India eClinical solutions market, by end-user, 2013 - 2024 (USD Million) 8.5. MEA 8.5.1. South Africa
Follow Us:
8.5.1.1. South Africa eClinical solutions market, by product, 2013 2024 (USD Million) 8.5.1.2. South Africa eClinical solutions market, by delivery mode, 2013 - 2024 (USD Million) 8.5.1.3. South Africa eClinical solutions market, by clinical trial, 2013 - 2024 (USD Million) 8.5.1.4. South Africa eClinical solutions market, by end-user, 2013 2024 (USD Million) 8.5.2. Saudi Arabia 8.5.2.1. Saudi Arabia eClinical solutions market, by product, 2013 2024 (USD Million) 8.5.2.2. Saudi Arabia eClinical solutions market, by delivery mode, 2013 - 2024 (USD Million) 8.5.2.3. Saudi Arabia eClinical solutions market, by clinical trial, 2013 - 2024 (USD Million) 8.5.2.4. Saudi Arabia eClinical solutions market, by end-user, 2013 - 2024 (USD Million) 8.6. Latin America 8.6.1. Brazil
Follow Us:
8.6.1.1. Brazil eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.6.1.2. Brazil eClinical solutions market, by delivery mode, 2013 2024 (USD Million) 8.6.1.3. Brazil eClinical solutions market, by clinical trial, 2013 2024 (USD Million) 8.6.1.4. Brazil eClinical solutions market, by end-user, 2013 - 2024 (USD Million) 8.6.2. Mexico 8.6.2.1. Mexico eClinical solutions market, by product, 2013 - 2024 (USD Million) 8.6.2.2. Mexico eClinical solutions market, by delivery mode, 2013 2024 (USD Million) 8.6.2.3. Mexico eClinical solutions market, by clinical trial, 2013 2024 (USD Million) 8.6.2.4. Mexico eClinical solutions market, by end-user, 2013 2024 (USD Million) Chapter 9. Competitive Landscape 9.1. Oracle Corporation 9.1.1. Company Overview
Follow Us:
9.1.2. Financial Performance 9.1.3. Product Benchmarking 9.1.4. Strategic Initiatives 9.2. Medidata Solutions Inc. 9.2.1. Company Overview 9.2.2. Financial Performance 9.2.3. Product Benchmarking 9.2.4. Strategic Initiatives 9.3. Parexel International Corporation 9.3.1. Company Overview 9.3.2. Financial Performance 9.3.3. Product Benchmarking 9.3.4. Strategic Initiatives 9.4. BioClinica 9.4.1. Company Overview 9.4.2. Financial Performance 9.4.3. Product Benchmarking
Follow Us:
9.4.4. Strategic Initiatives 9.5. Datatrak International Inc. 9.5.1. Company Overview 9.5.2. Financial Performance 9.5.3. Product Benchmarking 9.5.4. Strategic Initiatives 9.6. CRF Health 9.6.1. Company Overview 9.6.2. Financial Performance 9.6.3. Product Benchmarking 9.6.4. Strategic Initiatives 9.7. ERT 9.7.1. Company Overview 9.7.2. Financial Performance 9.7.3. Product Benchmarking 9.7.4. Strategic Initiatives 9.8. eClinical Solutions
Follow Us:
9.8.1. Company Overview 9.8.2. Financial Performance 9.8.3. Product Benchmarking 9.8.4. Strategic Initiatives 9.9. Merge Healthcare Inc. 9.9.1. Company Overview 9.9.2. Financial Performance 9.9.3. Product Benchmarking 9.9.4. Strategic Initiatives 9.10. OmniComm Systems Inc. 9.10.1. Company Overview 9.10.2. Financial Performance 9.10.3. Product Benchmarking 9.10.4. Strategic Initiatives
Follow Us:
About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com Web – http://www.grandviewresearch.com/
Follow Us: